Data Report

Covid19 => Covid Treatments => Topic started by: Data Report on March 12, 2025, 10:14:12 pm

Title: Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
Post by: Data Report on March 12, 2025, 10:14:12 pm

Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir.

This study was published on March 3, 2025

Source of information.

1. CIDRAP.

https://www.cidrap.umn.edu/covid-19/paxlovid-may-better-cut-risk-severe-covid-outcomes-asthma-patients-molnupiravir